Silicon Laboratories (SLAB) FY2016 results: revenue $698 million, up 8.2% on the year
Silicon Laboratories Inc. (SLAB) reported revenue of $698 million for fiscal 2016, the year ended 31 December 2016, up 8.2% on the year before. Net income was $61 million, up 107.8%, and diluted earnings per share $1.45. The figures are the company's own, from the 10-K it filed with the SEC on 30 January 2019.
Revenue
$698 million
+8.2% on the year
FY2009FY2016
Operating margin
9.5%
5.0% a year earlier
FY2009FY2016
Net income
$61 million
+107.8% on the year
FY2009FY2016
Diluted EPS
$1.45
+110.1% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
698
645
621
+8.2%
Cost of revenue
276
264
242
+4.6%
Gross profit
422
381
379
+10.7%
Gross margin
60.4%
59.1%
61.0%
Research and development
200
188
173
+6.2%
Selling, general and administrative
155
160
154
-3.1%
Operating income
66.3
32.2
51.4
+105.6%
Operating margin
9.5%
5.0%
8.3%
Interest expense
2.6
2.8
3.2
-8.5%
Pre-tax income
64.5
30.3
49.0
+113.1%
Income tax
3.0
0.7
11.0
+343.4%
Effective tax rate
4.7%
2.2%
22.5%
Net income
61.5
29.6
38.0
+107.8%
Net margin
8.8%
4.6%
6.1%
Diluted EPS
$1.45
$0.69
$0.87
+110.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
129
105
137
+22.3%
Capital expenditure
10.9
11.3
11.2
-3.0%
Free cash flow
118
94.2
126
+25.3%
Free cash flow margin
16.9%
14.6%
20.3%
Cash from investing
-49.6
-49.3
n/a
Cash from financing
-52.3
-83.8
n/a
Depreciation and amortisation
40.5
39.0
30.5
+3.8%
Share-based compensation
39.6
42.8
39.1
-7.4%
Buybacks
40.5
71.4
71.7
-43.3%
Diluted shares, weighted
42m
43m
44m
-1.3%
Shares outstanding at period end
42m
42m
42m
+0.4%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
827
761
758
+8.7%
Debt
72.5
77.5
87.5
-6.5%
Other liabilities
182
173
197
+5.5%
Total liabilities and equity
1,082
1,011
1,043
+7.0%
Fixed assets
130
131
133
-1.2%
Goodwill
276
273
229
+1.2%
Intangible assets
104
121
115
-14.7%
Investments
159
136
201
+17.0%
Cash and equivalents
141
114
142
+23.7%
Receivables
74.4
73.6
70.4
+1.1%
Inventory
59.6
53.9
52.6
+10.5%
Other assets
138
109
100
+27.3%
Total assets
1,082
1,011
1,043
+7.0%
10-K for the year ended 31 December 2016, filed 30 January 2019: the filing.